Detalles de la búsqueda
1.
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.
Breast Cancer Res Treat
; 201(3): 377-385, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37344660
2.
Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices.
Oncologist
; 27(12): 1008-1015, 2022 12 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215276
3.
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer.
Jpn J Clin Oncol
; 48(3): 242-247, 2018 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29315394
4.
Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial.
JAMA Oncol
; 10(3): 325-334, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127335
5.
Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis.
Cancer Med
; 12(19): 20035-20051, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37737544
6.
Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.
Oncologist
; 17(7): 970-7, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22673633
7.
Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives.
Ther Clin Risk Manag
; 17: 193-207, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33707948
8.
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients.
Breast
; 59: 211-220, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34298300
9.
A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women.
Environ Int
; 142: 105850, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580117
10.
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.
Sci Rep
; 5: 17879, 2015 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-26671300
11.
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country.
PLoS One
; 10(4): e0124908, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25909194
12.
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation.
J Clin Pathol
; 66(2): 140-5, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23268322
13.
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: a comparative study of the efficacy of anthracyclines and non-anthracyclines.
Breast
; 22(6): 1148-54, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23968865
14.
Prognostic molecular markers in women aged 35 years or younger with breast cancer: is there a difference from the older patients?
J Clin Pathol
; 64(9): 781-7, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21642658
15.
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation.
Anticancer Res
; 30(7): 3087-91, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20683060
16.
Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable!
J Clin Oncol
; 27(31): e179; author reply e180, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19738108
Resultados
1 -
16
de 16
1
Próxima >
>>